Literature DB >> 16141693

Sensitive liquid chromatographic assay for the simultaneous determination of ibuprofen and its prodrug, ibuprofen eugenol ester, in rat plasma.

Xiuli Zhao1, Dawei Chen, Kexin Li, Danlei Wang.   

Abstract

A rapid, sensitive, and specific reverse-phase high-performance liquid chromatography (HPLC) method was developed to quantitate ibuprofen (IBU) and its prodrug, ibuprofen eugenol ester (IEE), simultaneously in rat plasma. IBU, IEE, and the internal standard glycryrrhetic acid (GA) were detected by UV absorption at 230 nm. Extraction recoveries for all compounds ranged between 82.6% and 96.2%. Retention times of IBU, IEE, and GA were 5.62, 15.98, and 18.05 min, respectively. Calibration plots were linear over the range of 0.64 to 64 microg/ml for IBU, and 0.16 to 80 microg/ml for IEE. The limit of quantitation was 0.64 microg/ml for IBU and 0.16 microg/ml for IEE. The intra- and interday variations were less than 10% and accuracy was greater than 90%. The results showed that the established method is reproducible and sensitive and applicable to plasma samples collected from rats administered IBU and IEE intravenously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16141693     DOI: 10.1248/yakushi.125.733

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  3 in total

1.  Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.

Authors:  Clara Sciorati; Roberta Buono; Emanuele Azzoni; Silvana Casati; Pierangela Ciuffreda; Grazia D'Angelo; Dario Cattaneo; Silvia Brunelli; Emilio Clementi
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy.

Authors:  Clara Sciorati; Daniela Miglietta; Roberta Buono; Viviana Pisa; Dario Cattaneo; Emanuele Azzoni; Silvia Brunelli; Emilio Clementi
Journal:  Pharmacol Res       Date:  2011-05-12       Impact factor: 7.658

3.  Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers.

Authors:  Maria Vittoria Cossu; Dario Cattaneo; Serena Fucile; Paolo Pellegrino; Sara Baldelli; Valeria Cozzi; Amedeo Capetti; Emilio Clementi
Journal:  Drug Des Devel Ther       Date:  2014-05-02       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.